Skip to content
Pin icon

Resource Library

 Chat icon

Give feedback
Search for:

  • Resource type

  • Topic

  • Search for keywords in resource title

106 Results

The U.S. Generic & Biosimilar Medicines Savings Report (Sep. 2022)

Topics:

The Global Use of Medicines 2023

Topics:

Real-world evidence of a successful biosimilar adoption program

Topics:

National trends in prescription drug expenditures and projections for 2022

Topics:

Perceptions About Biosimilar Medicines Among Belgian Patients in the Ambulatory Care

Topics:

The Efficacy, Safety, and Immunogenicity of Switching Between Reference Biopharmaceuticals and Biosimilars: A Systematic Review

Topics:

Efficacy and Safety of Proposed Biosimilar Natalizumab (PB006) in Patients With Relapsing-Remitting Multiple Sclerosis

Topics:

Biosimilar Drugs for Multiple Sclerosis: An Unmet International Need or a Regulatory Risk?

Topics:

An Update Review of Biosimilars of Adalimumab in Psoriasis – Bioequivalence and Interchangeability

Topics:

Switching between reference adalimumab and biosimilars in chronic immune-mediated inflammatory diseases: A systematic literature review

Topics:

A Review of the Totality of Evidence Supporting the Development of the First Adalimumab Biosimilar ABP 501

Topics:

Review of Biosimilar Trials and Data on Adalimumab in Rheumatoid Arthritis

Topics:

Immunogenicity of Biosimilars for Rheumatic Diseases, Plaque Psoriasis, and Inflammatory Bowel Disease: A Review from Clinical Trials and Regulatory Documents

Topics:

A bio-what? Medical companions’ perceptions towards biosimilars and information needs in rheumatology

Topics:

Biosimilars Are Here: A Hospital Pharmacist’s Guide to Educating Health Care Professionals on Biosimilars

Topics:

Evaluation of Biosimilars for Formulary Inclusion: Factors for Consideration by P&T Committees

Topics:

Projected US Savings From Biosimilars, 2021-2025

Topics:
Page 2 of 6